Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
JAMA. 2023 Dec 5;330(21):2064-2074. doi: 10.1001/jama.2023.19918.
JAMA. 2023.
PMID: 38051328
Clinical Trial.
Sintilimab and Cardiovascular Toxicity-Reply.
Xu J; ORIENT-16 Investigators.
Xu J, et al.
JAMA. 2024 Apr 16;331(15):1334-1335. doi: 10.1001/jama.2024.0676.
JAMA. 2024.
PMID: 38512236
No abstract available.
Item in Clipboard
Cite
Cite